id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-277188-t33nw4zb	Fang, Jie	Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study	2020-09-18		.txt	text/plain	4641	227	46	RESULTS: The early combined usage of LHQW and Arbidol can significantly accelerate the recovery of patients with moderate COVID-19 by reducing the time to conversion to nucleic acid negativity, the time to chest CT improvement, and the length of hospital stay. One case report of four patients with mild or severe COVID-19 in Shanghai (China) found that combining antiviral drugs (lopinavir/ ritonavir or Arbidol) with TCM (Shufengjiedu capsule) resulted in a significant improvement in clinical symptoms . In conclusion, this retrospective study demonstrated that the early administration of LHQW + Arbidol combination therapy could significantly accelerate recovery in patients with moderate COVID-19 by reducing the time to conversion to nucleic acid Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 560209 negativity, the time to chest CT improvement and the length of hospital stay.	./cache/cord-277188-t33nw4zb.txt	./txt/cord-277188-t33nw4zb.txt